Lilly(Eli) (LLY) P/S (1999 - 2026)
Lilly(Eli) (LLY) P/S from Nov 1, 1999 to Jul 20, 2026. The TTM Lilly(Eli) (LLY) P/S is 14.19. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/S
Annual P/S change of Lilly(Eli) (LLY)
| Year | P/S | Change |
|---|---|---|
| 2026 | 14.19 | -4.03% |
| 2025 | 14.79 | -4.24% |
| 2024 | 15.44 | -5.57% |
| 2023 | 16.35 | +45.12% |
| 2022 | 11.27 | +27.42% |
| 2021 | 8.84 | +41.69% |
| 2020 | 6.24 | +15.98% |
| 2019 | 5.38 | -2.04% |
| 2018 | 5.49 | -56.72% |
| 2017 | 12.69 | +239.98% |
| 2016 | 3.73 | -16.68% |
| 2015 | 4.48 | +19.11% |
| 2014 | 3.76 | +57.83% |
| 2013 | 2.38 | +22.12% |
| 2012 | 1.95 | +25.45% |
| 2011 | 1.56 | +11.44% |
| 2010 | 1.40 | -7.73% |
| 2009 | 1.51 | +167.95% |
| 2008 | 0.56 | -14.57% |
| 2007 | 0.66 | +2.48% |
| 2006 | 0.65 | -7.93% |
| 2005 | 0.70 | -0.28% |
| 2004 | 0.70 | -19.31% |
| 2003 | 0.87 | +10.76% |
| 2002 | 0.79 | -19.15% |
| 2001 | 0.97 | -15.60% |
| 2000 | 1.15 | +39.94% |
| 1999 | 0.82 | N/A |
Comparison Lilly(Eli) (LLY) P/S with competitors
Lilly(Eli) (LLY) P/S is 14.19.
| Ticker | Name | P/S | Upside |
|---|---|---|---|
| OGN | Organon & Company | 0.57 | -95.95% |
| NVO | Novo Nordisk | 0.66 | -95.34% |
| GRFS | Grifols SA | 0.67 | -95.27% |
| AMRN | Amarin Corp | 1.39 | -90.21% |
| SCLX | Scilex Holding Company | 1.92 | -86.51% |
| SNY | Sanofi | 2.18 | -84.62% |
| PFE | Pfizer Inc | 2.18 | -84.62% |
| BMY | Bristol-Myers Squibb Company | 2.40 | -83.10% |
| BIIB | Biogen Inc | 2.93 | -79.36% |
| GSK | GSK Plc | 3.22 | -77.28% |
| MRK | Merck & Co Inc | 4.54 | -68.04% |
| AZN | Astrazeneca plc | 4.58 | -67.70% |
| NVS | Novartis AG | 5.07 | -64.28% |
| AMGN | AMGEN Inc | 5.15 | -63.71% |
| GILD | Gilead Sciences Inc | 5.43 | -61.74% |
| JNJ | Johnson & Johnson | 6.34 | -55.33% |
| ABBV | Abbvie Inc | 7.15 | -49.62% |